Long-Term Safety and Tolerability of the Lamivudine/Abacavir Combination as Components of Highly Active Antiretroviral Therapy

Author： Castillo Steve A.   Hernandez Jaime E.   Brothers Cindy H.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.29, Iss.9, 2006-01, pp. : 811-826

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abacavir and lamivudine combination

By Somboonwit Charurut   Kurtyka Don   Paula Velez Ana  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1599-1606

Informa Healthcare

Access to resources Recommend Favorite

Fixed-dose combination of abacavir, lamivudine and zidovudine for HIV therapy

By Milinkovic Ana   Mallolas Josep  

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 23-30

Future Medicine

Access to resources Recommend Favorite

Dolutegravir, abacavir and lamivudine as HIV therapy

By Fernandez-Montero Jose Vicente   Barreiro Pablo   Labarga Pablo   De Mendoza Carmen   Soriano Vicente  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 1051-1057

Informa Healthcare

Access to resources Recommend Favorite

The once-daily lamivudine plus abacavir fixed combination is noninferior to the twice daily regimen of the individual components

By  

Inpharma, Vol. 1, Iss. 1520, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Lamivudine/Zidovudine/Abacavir: Triple Combination Tablet

By Ibbotson T.   Perry C.M.  

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1089-1098

Adis International

Access to resources Recommend Favorite